Actively Recruiting
Molecularly Aided Stratification for Tumor Eradication Research
Led by German Cancer Research Center · Updated on 2025-03-04
10000
Participants Needed
1
Research Sites
568 weeks
Total Duration
On this page
Sponsors
G
German Cancer Research Center
Lead Sponsor
G
German Consortium for Translational Cancer Research
Collaborating Sponsor
AI-Summary
What this Trial Is About
NCT/DKFZ/DKTK MASTER is a prospective, continuously recruiting, multicenter observational study for biology-guided stratification of adults with rare cancers, including rare subtypes of common entities, using comprehensive molecular profiling, and clinical decision-making in a multidisciplinary molecular tumor board.
CONDITIONS
Official Title
Molecularly Aided Stratification for Tumor Eradication Research
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a rare cancer with an incidence of less than 6 per 100,000 persons per year or a rare subtype of a more common cancer as determined case-by-case
- Have metastatic and/or locally advanced cancer without a curative therapy option
- Have an indication for systemic therapy
- Be an adult aged 18 years or older
You will not qualify if you...
- Have a severe neurological or psychiatric disorder that interferes with the ability to provide oral and written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
German Cancer Research Center
Heidelberg, Germany, 69120
Actively Recruiting
Research Team
R
Richard F Schlenk, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here